-
@AcceleronPharma announces sotatercept achieved primary and secondary endpoints in the PULSAR trial http://bit.ly/36Qq5b5#VascularNews#pulmonaryarterialhypertension -
Reliability and responsiveness of incremental shuttle walk test to estimate exercise capacity in patients with pulmonary arterial hypertension R. Ishrat, A. Mujaddadi, M.S. Ali, D. Talwar, M.E. Hussain https://doi.org/10.3920/CEP190056 …
#CEPinPress#pulmonaryarterialhypertension -
This
@AcceleronPharma drug didn't pan out treating a rare blood disorder or chronic kidney disease. But with positive topline Phs 2 data in#pulmonaryarterialhypertension, some now see blockbuster potential.$XLRN shares shot up 50% Tues. https://xconomy.com/boston/2020/01/28/third-times-the-charm-as-acceleron-drug-shows-early-promise-in-pah/ …#PAH -
#papworthauthors new publication: Safety of riociguat for the treatment of pulmonary arterial hypertension: Final data cut from the expert registry. https://buff.ly/30ZJp4x .#pulmonaryArterialHypertension#PAH#riociguat -
Noninvasive prognostic biomarkers for left
#HeartFailure as predictors of survival in#PulmonaryArterialHypertension@accpchest |#ECM http://bit.ly/36v8eX1 -
Acceleron up 80%+ AH sotatercept after hits in
#PulmonaryArterialHypertension https://www.businesswire.com/news/home/20200127005650/en/Acceleron-Announces-Sotatercept-Achieved-Primary-Secondary-Endpoints …$XLRN -
Results of an Expert Delphi Consensus Survey on clinical scenarios considered when initiating oral prostacyclin pathway agents in the treatment of
#pulmonaryarterialhypertension#PAH. Learn more: http://ow.ly/S2pt50wihb1 pic.twitter.com/Q4mQ7bFcj5
-
“Bosentan Tablets, 62.5 mg and 125 mg have an estimated market size of $68 million for twelve months ending September 2019.”
#Bosentan#Bosentantablet#pulmonaryarterialhypertension https://www.myhealthyclick.com/fda-approves-bosentan-for-treatment-of-pulmonary-arterial-hypertension/ … -
Cardiologist Dr. Raymond Benza discusses
#PulmonaryArterialHypertension and$PHAS once weekly VIP analogue PB1046 currently in clinical trials for adults with#PAH. Listen to the@phaware podcast here.https://link.medium.com/EDXXBK4D21 -
Study suggests mechanical basis for using
#RightVentricle &#LeftVentricle end-diastolic volume ratio as clinical index for delineating disease severity, estimating RV free wall contractility in#PulmonaryArterialHypertension patients http://ow.ly/BAFM50xxq7F@simula_researchpic.twitter.com/xk28PuGfRl
-
Have you visited the
@MedTechStrat#CommunityBlog on http://MyStrategist.com ? Take a look at our archives for some great free content, such as this installation of#InMedTechHistory on#PulmonaryArterialHypertension: http://bit.ly/2DGzDcJ pic.twitter.com/txxWCyUwA5
-
Tomorrow the
#PAHPatientCharter will be available to everyone living with#PulmonaryArterialHypertension. Here’s a sneak peek from@PhDeutschland’s Daniela#PAH#WithYouUntilPHIsntpic.twitter.com/IKylE8vCwz -
CEO Martine Rothblatt (from today's
$UTHR earnings call):$MNKD#PulmonaryArterialHypertension#PAH#Lungs#BetterQualityOfLife#Health#Innovation#Technosphere#Biotech#BREEZEpic.twitter.com/RuwqPjy28j
-
mtROS-induced ca2+ entry via TRPV4 regulates mitochondrial morphology in lung microvascular endothelial cells. Read more here in AJP-Lung: https://buff.ly/2Utzdhl
@suresh_lab@Shimoda_Lab@damarlalab@HopkinsMedicine#PulmonaryArterialHypertension#PAH#Mitochondriapic.twitter.com/EZGOw1VjXV
-
Interesting work from
#JohnsHopkins on endostatin as a novel biomarker in#PulmonaryArterialHypertension Looking forward to reading the full paper someday@ERSpublications@EuroRespSoc#ERSCongress#ERS2019pic.twitter.com/d4h0LFoxqv
-
Recruiting has begun for the BREEZE study
$UTHR$MNKD#PulmonaryArterialHypertension#PAH#Lungs#BetterQualityOfLife#Health#Innovation#Technosphere#Biotech#BREEZE https://clinicaltrials.gov/ct2/show/NCT03950739 …pic.twitter.com/3veCYYySRM
-
"Technosphere Tech is extraordinary...Tyvaso market will Triple." -Wedbush PacGrow Health Conference
#PulmonaryArterialHypertension#PAH#Pulmonary#biotech#MedTech#Lungs$MNKD$UTHR https://ir.unither.com/events-presentations …pic.twitter.com/0rnzMdUz0I
-
Hey parents of
#disabled kids - my kid's bus driver for the afternoon refused to transport her little fold up wheelchair. The one written into her 504. Advice?#DisabilityRights#wheelchair#pulmonaryarterialhypertension#copd#lungdisease -
I Survived! Airplanes, Hospitals! Amazing adventure in San Antonio! Pul... https://youtu.be/NFIe-h5xDjg via
@YouTube#singersongwriter@TFCSATX#PulmonaryArterialHypertension
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.